Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study)

Affiliation auteurs!!!! Error affiliation !!!!
TitreDocetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study)
Type de publicationJournal Article
Year of Publication2017
AuteursKim S., Francois E., Bidard F-C., Samalin E., F. Hajbi E, Baba-Hamed N., Dumont S., Pernot S., Peiffert D., Ghiringhelli F., Bouche O., Desrame J., Zoubir M., Parzy A., Smith D., de la Fouchardiere C., Buecher B., Vendrely V., Bonnetain F., Borg C.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534